6.
Campeau L
. Letter: Grading of angina pectoris. Circulation. 1976; 54(3):522-3.
View
7.
Singh B, Roche A
. Effects of intravenous verapamil on hemodynamics in patients with heart disease. Am Heart J. 1977; 94(5):593-9.
DOI: 10.1016/s0002-8703(77)80128-2.
View
8.
Frishman W, Silverman R, Strom J, Elkayam U, Sonnenblick E
. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker. Am Heart J. 1979; 98(2):256-62.
DOI: 10.1016/0002-8703(79)90229-1.
View
9.
Battler A, ROSS Jr J, Slutsky R, Pfisterer M, Ashburn W, Froelicher V
. Improvement of exercise-induced left ventricular dysfunction with oral propranolol in patients with coronary heart disease. Am J Cardiol. 1979; 44(2):318-24.
DOI: 10.1016/0002-9149(79)90323-0.
View
10.
Frishman W, Kostis J, Strom J, Hossler M, Elkayam U, Goldner S
. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity. Am Heart J. 1979; 98(4):526-35.
DOI: 10.1016/0002-8703(79)90261-8.
View
11.
Crawford M, Lindenfeld J, ORourke R
. Effects of oral propranolol on left ventricular size and performance during exercise and acute pressure loading. Circulation. 1980; 61(3):549-54.
DOI: 10.1161/01.cir.61.3.549.
View
12.
Sorensen S, Ritchie J, Caldwell J, Hamilton G, Kennedy J
. Serial exercise radionuclide angiography. Validation of count-derived changes in cardiac output and quantitation of maximal exercise ventricular volume change after nitroglycerin and propranolol in normal men. Circulation. 1980; 61(3):600-9.
DOI: 10.1161/01.cir.61.3.600.
View
13.
Luz P, Monteiro de Barros L, Leite J, Pileggi F, DECOURT L
. Effect of verapamil on regional coronary and myocardial perfusion during acute coronary occlusion. Am J Cardiol. 1980; 45(2):269-75.
DOI: 10.1016/0002-9149(80)90645-1.
View
14.
Kawai C, Konishi T, Matsuyama E, Okazaki H
. Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies. Circulation. 1981; 63(5):1035-42.
DOI: 10.1161/01.cir.63.5.1035.
View
15.
Dehmer G, Falkoff M, Lewis S, Hillis L, Parkey R, Willerson J
. Effect of oral propranolol on rest and exercise left ventricular ejection fraction, volumes, and segmental wall motion in patients with angina pectoris. Assessment with equilibrium gated blood pool imaging. Br Heart J. 1981; 45(6):656-66.
PMC: 482579.
DOI: 10.1136/hrt.45.6.656.
View
16.
Subramanian B, Bowles M, Lahiri A, Davies A, Raftery E
. Long-term antianginal action of verapamil assessed with quantitated serial treadmill stress testing. Am J Cardiol. 1981; 48(3):529-35.
DOI: 10.1016/0002-9149(81)90084-9.
View
17.
PINE M, Citron P, Bailly D, Butman S, Plasencia G, Landa D
. Verapamil versus placebo in relieving stable angina pectoris. Circulation. 1982; 65(1):17-22.
DOI: 10.1161/01.cir.65.1.17.
View
18.
Manyari D, Nolewajka A, Purves P, Donner A, Kostuk W
. Comparative value of the cold-pressor test and supine bicycle exercise to detect subjects with coronary artery disease using radionuclide ventriculography. Circulation. 1982; 65(3):571-9.
DOI: 10.1161/01.cir.65.3.571.
View
19.
Taylor S, Silke B, Lee P
. Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?. N Engl J Med. 1982; 306(11):631-5.
DOI: 10.1056/NEJM198203183061102.
View
20.
Tan A, Sadick N, Kelly D, Harris P, Freedman S, BAUTOVICH G
. Verapamil in stable effort angina: effects on left ventricular function evaluated with exercise radionuclide ventriculography. Am J Cardiol. 1982; 49(2):425-30.
DOI: 10.1016/0002-9149(82)90520-3.
View